Jumping straight to a full dose invites a cascade of gastrointestinal side effects that can derail the entire protocol
The reduction in vascular oxidative stress is a key step in alleviating the heavy, aching limbs and cognitive dysfunction that plague so many patients
Looking ahead, ongoing clinical trials are investigating GLP-1s for an even wider range of conditions, including Alzheimer's disease and alcohol use disorder
A Smarter Approach to Weight Maintenance & Metabolic Health Microdosing GLP-1s: Get the Facts On This Growing Trend A Smarter, More Sustainable Approach for Both Men and Women Our Microdosing Protocol uses Doctor-Prescribed, low-dose GLP-1 medications like Tirzepatide to Gently Curb Appetite, Quiet Food Noise, and Support Metabolic Health as part of a Long-Term Weight Management Plan
GLP-1 drugs' potential use in preventing or controlling cancer was a major theme among the research presented at the influential American Society of Clinical Oncology meeting last month
He joined the FDA in 2023 as an Oak Ridge Institute for Science and Education (ORISE) Fellow with the Clinical Safety and Human Subject Research Team in the Division of Therapeutic Performance II (DTP II), Office of Research and Standards (ORS), under the Office of Generic Drugs (OGD) and is currently working as a contractor for the same team